Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes and Ramadan: Practical guidelines.
Hassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, Al-Madani A, Hanif W, Lessan N, Basit A, Tayeb K, Omar M, Abdallah K, Al Twaim A, Buyukbese MA, El-Sayed AA, Ben-Nakhi A; International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Hassanein M, et al. Diabetes Res Clin Pract. 2017 Apr;126:303-316. doi: 10.1016/j.diabres.2017.03.003. Epub 2017 Mar 12. Diabetes Res Clin Pract. 2017. PMID: 28347497 Free article. Review.
Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS).
Hassanein M, Echtay A, Hassoun A, Alarouj M, Afandi B, Poladian R, Bennakhi A, Nazar M, Bergmans P, Keim S, Hamilton G, Azar ST. Hassanein M, et al. Int J Clin Pract. 2017 Oct;71(10):e12991. doi: 10.1111/ijcp.12991. Epub 2017 Aug 29. Int J Clin Pract. 2017. PMID: 28851109 Free PMC article.
Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan.
Hassanein M, Echtay AS, Malek R, Omar M, Shaikh SS, Ekelund M, Kaplan K, Kamaruddin NA. Hassanein M, et al. Diabetes Res Clin Pract. 2018 Jan;135:218-226. doi: 10.1016/j.diabres.2017.11.027. Epub 2017 Nov 26. Diabetes Res Clin Pract. 2018. PMID: 29183844 Free article. Clinical Trial.
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes.
Hassanein M, Abdelgadir E, Bashier A, Rashid F, Saeed MA, Khalifa A, Eltayb F, Abuelkheir S, Abdellatif M, Sayyah F, Khalifa S, Alawadi F. Hassanein M, et al. Diabetes Res Clin Pract. 2019 Apr;150:288-295. doi: 10.1016/j.diabres.2018.12.013. Epub 2019 Jan 11. Diabetes Res Clin Pract. 2019. PMID: 30641167
Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
Bashier AMK, Hussain AKB, Alawadi F, Alsayyah F, Alsaeed M, Rashid F, Abdelgadir E, Bachet F, Abuelkheir S, Elsayed M, Hassanein M. Bashier AMK, et al. Among authors: hassanein m. Diabetes Res Clin Pract. 2019 Apr;150:301-307. doi: 10.1016/j.diabres.2019.01.037. Epub 2019 Feb 12. Diabetes Res Clin Pract. 2019. PMID: 30768940
Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS).
Hassanein M, Rashid F, Elsayed M, Basheir A, Al Saeed M, Abdelgadir E, AbuelKheir S, Khalifa A, Al Sayyah F, Bachet F, Jacob S, Alawadi F. Hassanein M, et al. Diabetes Res Clin Pract. 2019 Apr;150:308-314. doi: 10.1016/j.diabres.2019.01.038. Epub 2019 Feb 13. Diabetes Res Clin Pract. 2019. PMID: 30771364
Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial.
Hassanein MM, Sahay R, Hafidh K, Djaballah K, Li H, Azar S, Shehadeh N, Hanif W. Hassanein MM, et al. Diabetes Res Clin Pract. 2019 Apr;150:331-341. doi: 10.1016/j.diabres.2019.01.035. Epub 2019 Feb 14. Diabetes Res Clin Pract. 2019. PMID: 30772385 Free article. Clinical Trial.
360 results